208 related articles for article (PubMed ID: 21228568)
41. Dialyzer reprocessing: improved treatment quality and increased dialyzer reuse using a team approach.
Slyby T; Huff G; Henger MJ
Nephrol Nurs J; 2000 Oct; 27(5):483-8. PubMed ID: 16649323
[TBL] [Abstract][Full Text] [Related]
42. Medicare program; rural health clinics: amendments to participation requirements and payment provisions; and establishment of a quality assessment and performance improvement program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Dec; 68(247):74791-818. PubMed ID: 14976981
[TBL] [Abstract][Full Text] [Related]
43. Adequacy of peritoneal dialysis: a quality improvement project of The Renal Network, Inc (Illinois, Indiana, Kentucky, and Ohio).
Brier ME; Erbeck KM
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S36-9. PubMed ID: 11053585
[TBL] [Abstract][Full Text] [Related]
44. Medicare program; protocol for the reuse of dialysis bloodlines--HCFA. Final rule.
Fed Regist; 1990 May; 55(85):18331-5. PubMed ID: 10106630
[TBL] [Abstract][Full Text] [Related]
45. Medicaid program; relations with other agencies, miscellaneous Medicaid definitions, third party liability quality control, and limitations on federal funds for abortions--HCFA. Final rule.
Fed Regist; 1987 Dec; 52(242):47926-35. PubMed ID: 10302037
[TBL] [Abstract][Full Text] [Related]
46. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
47. The early history of dialysis for chronic renal failure in the United States: a view from Seattle.
Blagg CR
Am J Kidney Dis; 2007 Mar; 49(3):482-96. PubMed ID: 17336711
[TBL] [Abstract][Full Text] [Related]
48. Medicare Program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system changes and FY2011 rates; provider agreements and supplier approvals; and hospital conditions of participation for rehabilitation and respiratory care services; Medicaid program: accreditation for providers of inpatient psychiatric services. Final rules and interim final rule with comment period.
Centers for Medicare and Medicaid Services (CMS), HHS
Fed Regist; 2010 Aug; 75(157):50041-681. PubMed ID: 20712087
[TBL] [Abstract][Full Text] [Related]
49. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
Charytan C
Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
[TBL] [Abstract][Full Text] [Related]
50. The preliminary impact of Maryland's medical director and attending physician regulations.
Boyce BF; Bob H; Levenson SA
J Am Med Dir Assoc; 2003; 4(3):157-63. PubMed ID: 12854990
[TBL] [Abstract][Full Text] [Related]
51. How to make the new Conditions for Coverage work in your dialysis clinic. Patient assessment.
Deziel S; Bodin S
Nephrol News Issues; 2008 Dec; 22(13):38, 40, 42. PubMed ID: 19149316
[No Abstract] [Full Text] [Related]
52. Medicare program; Medicare coverage of screening mammography--HCFA. Interim final rule with comment.
Fed Regist; 1990 Dec; 55(251):53510-25. PubMed ID: 10108588
[TBL] [Abstract][Full Text] [Related]
53. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
54. Leading the Dialysis Unit: Role of the Medical Director.
Saha S; Wish JB
Adv Chronic Kidney Dis; 2018 Nov; 25(6):499-504. PubMed ID: 30527549
[TBL] [Abstract][Full Text] [Related]
55. Mission possible: vascular access-decreasing the use of catheters in the Texas hemodialysis community.
Rosenblum AJ; Harbert G; Knotek B; Husni L
Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S76-80. PubMed ID: 11053591
[TBL] [Abstract][Full Text] [Related]
56. Business of dialysis and the role of the medical director.
Scheel PJ
Semin Dial; 2018 Mar; 31(2):177-182. PubMed ID: 29377277
[TBL] [Abstract][Full Text] [Related]
57. Medicare program; end-stage renal disease program; prospective reimbursement for dialysis services and approval of special purpose renal dialysis facilities--HCFA. Final rule.
Fed Regist; 1983 May; 48(92):21254-91. PubMed ID: 10299129
[TBL] [Abstract][Full Text] [Related]
58. Medicare program; payment change for home dialysis--HCFA. Final rule.
Fed Regist; 1992 Nov; 57(222):54179-88. PubMed ID: 10122660
[TBL] [Abstract][Full Text] [Related]
59. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace.
Lowrie EG; Hampers CL
N Engl J Med; 1981 Aug; 305(8):434-8. PubMed ID: 7019710
[TBL] [Abstract][Full Text] [Related]
60. Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers.
Fishbane S; Hazzan A
Am J Kidney Dis; 2012 Nov; 60(5 Suppl 1):S5-13; quiz S14-7. PubMed ID: 23063058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
